Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism

细胞色素 P450 介导的药物代谢建模的新计算方法

基本信息

  • 批准号:
    8706177
  • 负责人:
  • 金额:
    $ 19.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The metabolism of drugs and other xenobiotics by cytochrome P450 enzymes (CYP) is an essential detoxification and drug clearance mechanism in humans. Despite the publication of several X-ray structures since 2000, reliable computational prediction of drug metabolism remains a huge challenge. In this grant application, we propose an integrative high-throughput approach that combines electronic properties of a ligand with structural properties of the protein. Our main aim is the development and application of innovative structure-based design techniques that address serious shortcomings of current approaches. In particular, we have extended our novel docking concept to incorporate all observed forms of protein flexibility relevant for ligand-CYP interactions, entropic contributions influencing the prediction of binding poses, and we will add on- the-fly solvation to ligand-CYP complexes. To improve the docking quality we will optimize the parameters of a scoring function tailor-made for each CYP enzyme studied. In combination with an initial focus on efficient calculation of hydrogen-abstraction energies we will predict regioselective metabolism of drugs or drug candidates binding to CYPs. Based on the resulting docking poses, multidimensional QSAR simulations will be performed for accurate quantification of binding affinity as a measure CYP-inhibition and better ranking of binding modes. The new computational methods will be applied to two CYP enzymes (CYP2C9, 3A4) important in drug metabolism. The generated computational models will be stored in a database and made publicly available. Other researchers will be invited to screen compounds against our CYP database via a secure Web protocol to predict drug metabolism and inhibition. The submission of data by other researchers will provide valuable feedback on the performance and applicability of the models.
描述(由申请人提供):细胞色素 P450 酶(CYP)对药物和其他外源物质的代谢是人类重要的解毒和药物清除机制。尽管自 2000 年以来已经发表了多种 X 射线结构,但药物代谢的可靠计算预测仍然是一个巨大的挑战。在这项拨款申请中,我们提出了一种综合高通量方法,将配体的电子特性与蛋白质的结构特性相结合。我们的主要目标是开发和应用基于结构的创新设计技术,以解决当前方法的严重缺陷。特别是,我们扩展了我们的新颖对接概念,以纳入与配体-CYP相互作用相关的所有观察到的蛋白质灵活性形式、影响结合姿势预测的熵贡献,并且我们将在配体-CYP复合物中添加动态溶剂化。为了提高对接质量,我们将优化为所研究的每种 CYP 酶量身定制的评分函数的参数。结合最初对氢抽象能量的有效计算的关注,我们将预测药物或候选药物与 CYP 结合的区域选择性代谢。基于所得的对接姿势,将进行多维 QSAR 模拟,以准确量化结合亲和力,作为 CYP 抑制的衡量标准和更好的结合模式排名。新的计算方法将应用于药物代谢中重要的两种 CYP 酶(CYP2C9、3A4)。生成的计算模型将存储在数据库中并公开可用。其他研究人员将被邀请通过安全的网络协议根据我们的 CYP 数据库筛选化合物,以预测药物代谢和抑制。其他研究人员提交的数据将为模型的性能和适用性提供有价值的反馈。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
WATsite: hydration site prediction program with PyMOL interface.
Watsite:带有Pymol界面的水合站点预测计划。
  • DOI:
    10.1002/jcc.23616
  • 发表时间:
    2014-06-15
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Hu, Bingjie;Lill, Markus A.
  • 通讯作者:
    Lill, Markus A.
Ensemble generation and the influence of protein flexibility on geometric tunnel prediction in cytochrome P450 enzymes.
  • DOI:
    10.1371/journal.pone.0099408
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Kingsley LJ;Lill MA
  • 通讯作者:
    Lill MA
Exploring the potential of protein-based pharmacophore models in ligand pose prediction and ranking.
Substrate tunnels in enzymes: structure-function relationships and computational methodology.
Induced fit docking, and the use of QM/MM methods in docking.
  • DOI:
    10.1016/j.ddtec.2013.02.003
  • 发表时间:
    2013-09
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Xu, Mengang;Lill, Markus A
  • 通讯作者:
    Lill, Markus A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Markus Alexander Lill其他文献

Markus Alexander Lill的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Markus Alexander Lill', 18)}}的其他基金

Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism
细胞色素 P450 介导的药物代谢建模的新计算方法
  • 批准号:
    8304931
  • 财政年份:
    2010
  • 资助金额:
    $ 19.99万
  • 项目类别:
Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism
细胞色素 P450 介导的药物代谢建模的新计算方法
  • 批准号:
    7991977
  • 财政年份:
    2010
  • 资助金额:
    $ 19.99万
  • 项目类别:
Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism
细胞色素 P450 介导的药物代谢建模的新计算方法
  • 批准号:
    8134421
  • 财政年份:
    2010
  • 资助金额:
    $ 19.99万
  • 项目类别:
Novel Computational Methods for Modeling Cytochrome P450 Mediated Drug Metabolism
细胞色素 P450 介导的药物代谢建模的新计算方法
  • 批准号:
    8515459
  • 财政年份:
    2010
  • 资助金额:
    $ 19.99万
  • 项目类别:
Dynamic Scoring: A novel method for quantitative modeling of guest-host associati
动态评分:宾主关联定量建模的新方法
  • 批准号:
    7510816
  • 财政年份:
    2008
  • 资助金额:
    $ 19.99万
  • 项目类别:
Dynamic Scoring: A novel method for quantitative modeling of guest-host associati
动态评分:宾主关联定量建模的新方法
  • 批准号:
    7663070
  • 财政年份:
    2008
  • 资助金额:
    $ 19.99万
  • 项目类别:

相似海外基金

A personalised approach to manage adverse reactions to CFTR modulator therapy in patients with cystic fibrosis
治疗囊性纤维化患者 CFTR 调节剂治疗不良反应的个性化方法
  • 批准号:
    MR/X00094X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Research Grant
Identifying genetic polymorphisms and elucidating polygenic architecture associated with adverse reactions due to rituximab
识别遗传多态性并阐明与利妥昔单抗不良反应相关的多基因结构
  • 批准号:
    22K15910
  • 财政年份:
    2022
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanistic study of sulfa drug-induced severe cutaneous adverse reactions by focusing on HLA-A*11:01
以HLA-A*为重点的磺胺类药物致严重皮肤不良反应机制研究11:01
  • 批准号:
    22K06738
  • 财政年份:
    2022
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
  • 批准号:
    449379
  • 财政年份:
    2020
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Studentship Programs
Significance of gamma-chain in severe cutaneous adverse reactions
伽马链在严重皮肤不良反应中的意义
  • 批准号:
    19K17779
  • 财政年份:
    2019
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Historical sociology of adverse reactions related to vaccination in Japan
日本疫苗接种不良反应的历史社会学
  • 批准号:
    18K00267
  • 财政年份:
    2018
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SEARCH (active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare) & PREVENT (Pharmacogenomics of Adverse Reaction EVEnts National Team)
SEARCH(加拿大医疗保健不良反应的主动监测和评估)
  • 批准号:
    379425
  • 财政年份:
    2018
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Operating Grants
IGF::OT::IGF SBIR Phase II: Topic 338 - Predictive Biomarkers of Adverse Reactions to Prostrate Cancer Radiotherapy
IGF::OT::IGF SBIR II 期:主题 338 - 前列腺癌放射治疗不良反应的预测生物标志物
  • 批准号:
    9576448
  • 财政年份:
    2017
  • 资助金额:
    $ 19.99万
  • 项目类别:
Development of in silico prediction method for idiosyncratic adverse reactions associated with HLA genotypes
与 HLA 基因型相关的特殊不良反应的计算机预测方法的开发
  • 批准号:
    16K15156
  • 财政年份:
    2016
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Characterising the Immune Response to Drugs That Cause Idiosyncratic Adverse Reactions
表征对引起特殊不良反应的药物的免疫反应
  • 批准号:
    367156
  • 财政年份:
    2016
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了